A detailed history of Transcend Capital Advisors, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 26,500 shares of PRME stock, worth $89,305. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,500
Holding current value
$89,305
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$3.33 - $6.67 $88,245 - $176,755
26,500 New
26,500 $89,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $323M
More about PRME
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.